Zobrazeno 1 - 6 of 6 pro vyhledávání: '"Uyen Y. Doan"'
1
Akademický článek
Safety and immunogenicity of Nanocovax, a SARS-CoV-2 recombinant spike protein vaccine: Interim results of a double-blind, randomised controlled phase 1 and 2 trial
Autor: Thuy P. Nguyen, Quyet Do, Lan T. Phan, Duc V. Dinh, Hiep Khong, Luong V. Hoang, Thuong V. Nguyen, Hung N. Pham, Men V. Chu, Toan T. Nguyen, Quang D. Pham, Tri M. Le, Tuyen N.T. Trang, Thanh T. Dinh, Thuong V. Vo, Thao T. Vu, Quynh B.P. Nguyen, Vuong T. Phan, Luong V. Nguyen, Giang T. Nguyen, Phong M. Tran, Thuan D. Nghiem, Tien V. Tran, Tien G. Nguyen, Tuynh Q. Tran, Linh T. Nguyen, Anh T. Do, Dung D. Nguyen, Son A. Ho, Viet T. Nguyen, Dung T. Pham, Hieu B. Tran, Son T. Vu, Su X. Hoang, Trung M. Do, Xuan T. Nguyen, Giang Q. Le, Ton Tran, Thang M. Cao, Huy M. Dao, Thao T.T. Nguyen, Uyen Y Doan, Vy T.T. Le, Linh P. Tran, Ngoc M. Nguyen, Ngoc T. Nguyen, Hang T.T. Pham, Quan H. Nguyen, Hieu T. Nguyen, Hang L.K. Nguyen, Vinh T. Tran, Mai T.N. Tran, Truc T.T. Nguyen, Phat T. Ha, Hieu T. Huynh, Khanh D. Nguyen, Ung T. Thuan, Chung C. Doan, Si M. Do
Publikováno v: The Lancet Regional Health. Western Pacific, Vol 24, Iss , Pp 100474- (2022)
Summary: Background: Nanocovax is a recombinant severe acute respiratory syndrome coronavirus 2 subunit vaccine composed of full-length prefusion stabilized recombinant SARS-CoV-2 spike glycoproteins (S-2P) and aluminium hydroxide adjuvant. Methods:
Externí odkaz: https://doaj.org/article/859ef0abb94344f8b95f26d0929726c8
Zobrazit plný text záznamu
2
The efficacy, safety and immunogenicity Nanocovax: results of a randomized, double-blind, placebo-controlled Phase 3 trial
Autor: Thuy P. Nguyen, Quyet Do, Lan T. Phan, Dang D. Anh, Hiep Khong, Thuong V. Nguyen, Luong V. Hoang, Duc V. Dinh, Hung N. Pham, Men V. Chu, Toan T. Nguyen, Quang D. Pham, Tri M. Le, Tuyen N.T. Trang, Thanh T. Dinh, Thuong V. Vo, Thao T. Vu, Quynh B.P. Nguyen, Vuong T. Phan, Luong V. Nguyen, Giang T. Nguyen, Phong M. Tran, Thuan D. Nghiem, Tien V. Tran, Tien G. Nguyen, Tuynh Q. Tran, Linh T. Nguyen, Anh T. Do, Dung D. Nguyen, Son A. Ho, Viet T. Nguyen, Dung T. Pham, Hieu B. Tran, Son T. Vu, Su X. Hoang, Trung M. Do, Xuan T. Nguyen, Giang Q. Le, Ton Tran, Thang M. Cao, Huy M. Dao, Thao T.T. Nguyen, Uyen Y Doan, Vy T.T. Le, Linh P. Tran, Ngoc M. Nguyen, Ngoc T. Nguyen, Hang T.T. Pham, Quan H. Nguyen, Hieu T. Nguyen, Hang L.K. Nguyen, Nguyen V. Trang, Anh T.L. Nguyen, Anh P. Nguyen, Nhung T.H. Trinh, Ly T.K. Le, Van T. B. Tran, Mai T. N. Chu, My H. Phan, Hoa T. H. Nguyen, Vinh T. Tran, Mai T.N. Tran, Truc T.T. Nguyen, Phat T. Ha, Hieu T. Huynh, Khanh D. Nguyen, Nghia H.T. Duong, Ung T. Thuan, Chung C. Doan, null May, Si M. Do
SummaryBackgroundNanocovax is a recombinant severe acute respiratory syndrome coronavirus 2 subunit vaccine composed of full-length prefusion stabilized recombinant SARS-CoV-2 spike glycoproteins (S-2P) and aluminum hydroxide adjuvant. In a Phase 1 a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e218314b1934c27d528a91acefc84e90
https://doi.org/10.1101/2022.03.22.22272739
Zobrazit plný text záznamu
4
Safety of a quadrivalent meningococcal conjugate vaccine in healthy subjects aged 9 months to 55 years in Vietnam
Autor: Yaël Thollot, Cong Hung Phan, Maria Carmen Nievera, Thi Phuong Thuy Nguyen, Uyen Y. Doan, Thuy An Nguyen
Publikováno v: Pharmacoepidemiology and Drug Safety. 28:515-520
PURPOSE Meningococcal disease is a major global health concern due to its severe and sudden clinical manifestations, devastating long-term sequelae, and predominance in younger age groups. This study evaluated the safety of a quadrivalent meningococc
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6b72cf51be1c290f5eb20cfba828d62
https://doi.org/10.1002/pds.4754
Zobrazit plný text záznamu
5
Safety and Immunogenicity of Nanocovax, a SARS-CoV-2 Recombinant Spike Protein Vaccine
Autor: Thuy Phuong Nguyen, Quyet Do, Phan Trong Lan, Duc Viet Dinh, Hiep Khong, Luong Van Hoang, Thuong Vu Nguyen, Hung Pham Ngoc, Men Van Chu, Toan Trong Nguyen, Quang Duy Pham, Tri Minh Le, Tuyen Thi Ngoc Trang, Thanh Thi Dinh, Thuong Van Vo, Thao Thi Thu Vu, Quynh Bao Phuong Nguyen, Vuong Tan Phan, Luong Viet Nguyen, Giang Truong Nguyen, Phong Minh Tran, Thuan Duc Nghiem, Tien Viet Tran, Tien Gia Nguyen, Tuynh Quang Tran, Linh Tung Nguyen, Anh Tuan Do, Dung Dang Nguyen, Son Anh Ho, Viet Thanh Nguyen, Dung T. Pham, Hieu Ba Tran, Son Tung Vu, Hoan Ngoc Vu, Cuong Xuan Hoang, Su Xuan Hoang, Trung Minh Do, Xuan Thanh Nguyen, Giang Quynh Le, Ton Tran, Thang Minh Cao, Huy Manh Dao, Thao Thi Thanh Nguyen, Uyen Y. Doan, Le Thi Tuong Vy, Linh Phuong Tran, Ngoc Minh Nguyen, Ngoc Thu Nguyen, Hang Thi Thu Pham, Quan Hoang Nguyen, Hieu Trung Nguyen, Hang Le Khanh Nguyen, Vinh The Tran, Mai Thi Nhu Tran, Truc Thi Thanh Nguyen, Phat Tan Ha, Hieu Trong Huynh, Khanh Duy Nguyen, Thuan Trong Ung, Chung Chinh Doan, Si Minh Do
Publikováno v: SSRN Electronic Journal.
Background: Nanocovax is a recombinant severe acute respiratory syndrome coronavirus 2 subunit vaccine composed of full-length prefusion stabilized recombinant SARS-CoV-2 spike glycoproteins (S-2P) and aluminum hydroxide adjuvant. Methods: We conduct
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::42a48800933303aec393eff6495d3f06
https://doi.org/10.2139/ssrn.3931736
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje